VEL-0230, identified by its CAS number 221144-20-3, is a chemical compound that has garnered attention in the field of medicinal chemistry. While specific details about its characteristics may vary, it is generally recognized for its potential therapeutic applications. The compound is typically characterized by its molecular structure, which influences its reactivity and interaction with biological systems. VEL-0230 may exhibit properties such as solubility in various solvents, stability under specific conditions, and a defined mechanism of action relevant to its pharmacological effects. Additionally, its safety profile, including toxicity and side effects, is crucial for its evaluation in clinical settings. As with many compounds in drug development, ongoing research is essential to fully elucidate its characteristics and potential uses. For precise information regarding its physical and chemical properties, consulting specialized databases or scientific literature is recommended.

VEL-0230

221144-20-3: VEL-0230, identified by its CAS number 221144-20-3, is a chemical compound that has garnered attention in the field of medicinal chemistry. While specific details about its characteristics may vary, it is generally recognized for its potential therapeutic applications. The compound is typically characterized by its molecular structure, which influences its reactivity and interaction with biological systems. VEL-0230 may exhibit properties such as solubility in various solvents, stability under specific conditions, and a defined mechanism of action relevant to its pharmacological effects. Additionally, its safety profile, including toxicity and side effects, is crucial for its evaluation in clinical settings. As with many compounds in drug development, ongoing research is essential to fully elucidate its characteristics and potential uses. For precise information regarding its physical and chemical properties, consulting specialized databases or scientific literature is recommended.

<p>VEL-0230 (NC-2300) is a cathespin K inhibitor boosting bone growth and reducing loss, targeting bone diseases and developed by Velcura Therapeutics.</p>

CAS 221144-20-3

VEL-0230

VEL-0230

Ref: TM-T69793